CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.49B, above the global median of $1.15B
- FinancialsAltman Z-Score 5.92: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.51%Above 5Y avg (0.23%)
Annual Rate
KRW 2000.00Paid annual
Payout Ratio
14.7%Sustainable
Last Ex-Dividend
Mar 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.93TKRW3.49B · vs all stocks (USD)
Trailing P/E
29.05xRevenue (TTM)
1.55TKRW1.10B · vs all stocks (USD)
Profit Margin
11.13%Beta
0.4870xvs all stocks
52-Week Change
37.52%vs all stocks
Market Capitalization
4.93TKRW3.49B · vs all stocks (USD)
Enterprise Value
5.27TKRW3.73B · vs all stocks (USD)
Trailing P/E
29.05xForward P/E
22.97xPEG Ratio
4.32xPrice to Sales (TTM)
3.21xPrice to Book (MRQ)
3.33xEnterprise to Revenue
3.40xEnterprise to EBITDA
17.03xGross Margin
55.30%Profit Margin
11.13%Operating Margin
11.64%Return on Assets (TTM)
6.25%Return on Equity (TTM)
14.09%Revenue (TTM)
1.55TKRW1.10B · vs all stocks (USD)
Revenue per Share (TTM)
122.18KKRWUpdated Aug 19, 2026Quarterly Revenue Growth
0.50%Gross Profit (TTM)
888.10BKRW628.81M · vs all stocks (USD)
EBITDA (TTM)
500.83BKRW354.60M · vs all stocks (USD)
Net Income (TTM)
172.44BKRW122.09M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.80%Operating Cash Flow (TTM)
205.37BKRW145.41M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
35.94BKRW25.45M · vs all stocks (USD)
Trailing Annual Dividend Rate
2.00KKRWUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.51%vs all stocks
5-Year Average Dividend Yield
0.23%vs all stocks
Payout Ratio
14.72%Minority Interest (Equity)
173.10BKRWFY2025 · Dec 31, 2025Revenue
1.55TKRWFY2025 · Dec 31, 2025Cost of Goods Sold
663.12BKRWFY2025 · Dec 31, 2025Gross Profit
884.41BKRWFY2025 · Dec 31, 2025Operating Income
257.80BKRW182.53M · vs all stocks (USD)
Pre-tax Income
213.48BKRWFY2025 · Dec 31, 2025Income Tax Expense
26.34BKRWFY2025 · Dec 31, 2025Net Income
187.14BKRWFY2025 · Dec 31, 2025EBIT
230.46BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
373.04BKRWFY2025 · Dec 31, 2025Research & Development
195.83BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
225.89BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
7.27BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
16.99BKRWFY2025 · Dec 31, 2025EPS (Basic)
13.37KKRWFY2025 · Dec 31, 2025EPS (Diluted)
13.36KKRWFY2025 · Dec 31, 2025Basic Shares Outstanding
12.68MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
12.68MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
187.14BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
-17.58BKRWFY2025 · Dec 31, 2025Operating Cash Flow
37.70BKRWFY2025 · Dec 31, 2025Free Cash Flow
-4.86BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
108.27BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
187.14BKRWFY2025 · Dec 31, 2025Other Non-cash Items
13.10BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-87.25BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-75.28BKRWFY2025 · Dec 31, 2025Capital Expenditures
-42.56BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-33.00BKRWFY2025 · Dec 31, 2025Purchase of Investments
-113.41BKRWFY2025 · Dec 31, 2025Sale of Investments
59.78BKRWFY2025 · Dec 31, 2025Other Investing Activity
-3.97BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-100.16BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
38.00BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-243.24BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-81.84BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-30.86BKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-317.93BKRWFY2025 · Dec 31, 2025Shares Outstanding
12.68MSharesUpdated Aug 19, 2026Float Shares
6.27MSharesUpdated Aug 19, 2026% Held by Insiders
50.09%vs all stocks
% Held by Institutions
22.20%vs all stocks
Total Cash (MRQ)
298.38BKRW211.27M · vs all stocks (USD)
Total Cash per Share (MRQ)
23.51KKRWUpdated Aug 19, 2026Total Debt (MRQ)
418.36BKRW296.22M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2829xCurrent Ratio (MRQ)
1.54xBook Value per Share (MRQ)
116.56KKRWUpdated Aug 19, 2026Total Assets
2.14TKRW1.51B · vs all stocks (USD)
Total Current Assets
893.95BKRWFY2025 · Dec 31, 2025Total Liabilities
714.74BKRWFY2025 · Dec 31, 2025Total Non-current Assets
1.24TKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
109.54BKRWFY2025 · Dec 31, 2025Total Current Liabilities
605.20BKRWFY2025 · Dec 31, 2025Cash Equivalents
108.27BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
108.27BKRWFY2025 · Dec 31, 2025Other Short-term Investments
93.05BKRWFY2025 · Dec 31, 2025Accounts Receivable
337.29BKRWFY2025 · Dec 31, 2025Inventory
338.53BKRWFY2025 · Dec 31, 2025Accounts Payable
54.25BKRWFY2025 · Dec 31, 2025Short-term Debt
337.49BKRWFY2025 · Dec 31, 2025Other Current Liabilities
-830.00KRWFY2025 · Dec 31, 2025Long-term Debt
96.73BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-210.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
32.03BKRWFY2025 · Dec 31, 2025Retained Earnings
836.49BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
1.42TKRW1.01B · vs all stocks (USD)
Treasury Stock
43.33BKRWFY2025 · Dec 31, 202552-Week Low
275.50KKRWUpdated Aug 19, 202652-Week High
647.00KKRWUpdated Aug 19, 202652-Week Change
37.52%vs all stocks
Beta
0.4870xvs all stocks
50-Day MA
397.48KKRWUpdated Aug 19, 2026200-Day MA
463.58KKRWUpdated Aug 19, 2026Avg 10-Day Volume
69.29KSharesUpdated Aug 19, 2026Avg 30-Day Volume
88.23KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
13.36KKRWUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.92: safe zoneNotable
Altman Z-Score: 5.92
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.49B, above the global median of $1.15BNotable
Market cap (USD): 3,487,991,352.938Global Median: 1,146,734,693.424
Revenue is $1.1B, above the global median of $520.53MNotable
Revenue (USD): 1,097,114,028.406Global Median: 520,528,949.311
Levered free cash flow is $25.45M, above the global median of $16.24MNotable
Levered free cash flow (USD): 25,446,647.105Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Alumis Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Ideaya Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Pegbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Arcus Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hubei Jumpcan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Haemonetics Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Nhwa Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tasly Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Organon & Co.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hualan Biological Engineering Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
KC Tech Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Longhua Technology Group Luoyang Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Hubei Jiuzhiyang Infrared Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated